FDA Targets Philips' Imaging Manufacturing Facility With Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
FDA has cited Philips Medical Systems for more than 16 quality system deficiencies, including design controls, late reporting of device malfunctions and other violations concerning the firm’s computer tomography imaging and nuclear medicine products.